Contraline Stock
Contraline is developing the first long-lasting, reversible contraceptive for men
Sign up today and learn more about Contraline Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Contraline Stock
Contraline is a biotechnology company developing a long-lasting, non-hormonal, and reversible male contraceptive.
Funding History
| July 2014 | $0 |
|---|---|
| June 2016 | $680K |
| March 2017 | $2.3M |
| July 2018 | $0 |
| September 2018 | $0 |
Management
COO
Nicole E. Hastings
Co-Founder & CEO
Kevin Eisenfrats
Press
femtechinsider - Mar, 1 2024
Contraline's First-in-Human Clinical Trial Shows Promise for Novel Male Contraceptivemedriva - Mar, 1 2024
The Future of Male Contraception: Contraline's Revolutionary Injectable Hydrogelmedcitynews - Feb, 10 2024
Trial Data Looks Promising for 'IUD For Men'femtechinsider - Jan, 19 2024
Nature Study: Fairtility's CHLOE AI Supports Academic ...wired - Jan, 19 2024
The US Supreme Court Will Decide the Fate of Medication ...EquityZen Recognized As:
